Results
1 -
10 of
70
(Click
here to explore results)
Electrochemical Detection in HPLC: Analysis of Drugs and Poisons, Applications of HPLC-ED in the analysis of drugs . Roger M. Smith, Robert J. Flanagan, David Perrett, Robin Whelpton
, 2005
, Pages 104-210
The Alkaloids: Volume 4, The aporphines . J. E. Saxton, M. Shamma, S. S. Salgar
, 1974
, Volume 4
, Pages 197-265
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 5 Pharmacologic Management of Dopaminergic‐Induced Dyskinesias in Parkinson’s Disease . Mildred D. Gottwald, Michael J. Aminoff
, 2013
, Pages 110-125
Foreign Compound Metabolism in Mammals: Volume 5, Effect of drugs on the central nervous system . D. E. Hathway, B. E. Leonard
, 1979
, Volume 5
, Pages 244-319
Drug Discovery for Psychiatric Disorders, CHAPTER 3 Monoaminergic Approaches for Treatment of Schizophrenia . David P. Rotella
, 2012
, Pages 35-55
Forensic Chemistry of Substance Misuse: A Guide to Drug Control (2), CHAPTER 22 Morphine, Heroin and Other Opiates
, 2022
, Pages 273-280
The Alkaloids: Volume 8, Aporphinoid alkaloids . M. F. Grundon, M. Shamma
, 1978
, Volume 8
, Pages 122-136
Drug Discovery for Schizophrenia, CHAPTER 4 The Self-medication Hypothesis in Schizophrenia: What Have We Learned from Animal Models? . Bernard Le Foll, Enoch Ng, José M. Trigo, Patricia Di Ciano
, 2015
, Pages 70-88
Oxidative Stress and Redox Signalling in Parkinson’s Disease, CHAPTER 14 Dietary Anti-, Pro-Oxidants in the Etiology of Parkinson’s Disease . Zeynep Sena Agim, Jason R. Cannon
, 2017
, Pages 447-504
The Alkaloids: Volume 13, Aporphinoid alkaloids . M. F. Grundon, M. Shamma, H. Guinaudeau
, 1983
, Volume 13
, Pages 172-186